Matches in Nanopublications for { ?s ?p "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- NP342274.RAfz_UOf4hAvoLp9IfU4-wECGcefT9_4inVBPG8XR89FM130_assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342274.RAfz_UOf4hAvoLp9IfU4-wECGcefT9_4inVBPG8XR89FM130_provenance.
- NP501567.RAiO1Aqf61sMwx91I5nd2b8tGGWbziqNpRdpClwJRpq0M130_assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501567.RAiO1Aqf61sMwx91I5nd2b8tGGWbziqNpRdpClwJRpq0M130_provenance.
- NP479480.RA7-HulOWKlzwkcvq1h8bzLcd6Qb1wSQQnpk00w73c3AI130_assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP479480.RA7-HulOWKlzwkcvq1h8bzLcd6Qb1wSQQnpk00w73c3AI130_provenance.
- NP810633.RAHFzM8SmmjezZxTSdwk06yEykf792fJNmJP1cC8ofgic130_assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810633.RAHFzM8SmmjezZxTSdwk06yEykf792fJNmJP1cC8ofgic130_provenance.
- NP362451.RAzDs-M0Fr1rjhUfqrSR0JOKl-S7EnnRv-UeqzTQNyoZM130_assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP362451.RAzDs-M0Fr1rjhUfqrSR0JOKl-S7EnnRv-UeqzTQNyoZM130_provenance.
- NP475130.RA55WEIPd7UooA2cXbRBKAlKDV8I9jNrXfYUkbF1i9zXc130_assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475130.RA55WEIPd7UooA2cXbRBKAlKDV8I9jNrXfYUkbF1i9zXc130_provenance.
- assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP791145.RA87Fsiwz2kI30GTc2znCp-IFrada38W9En8uKuX920ZQ130_assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP791145.RA87Fsiwz2kI30GTc2znCp-IFrada38W9En8uKuX920ZQ130_provenance.
- assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP754507.RAv2Q6cQwBJi19TyxFga4eKXN_6O3ngTgU7hn8y2OdKYc130_assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754507.RAv2Q6cQwBJi19TyxFga4eKXN_6O3ngTgU7hn8y2OdKYc130_provenance.
- NP791146.RAFgZnl4RZb4jF409-4CPjACQp0Jm3L0PZYKCEHDeXX1M130_assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP791146.RAFgZnl4RZb4jF409-4CPjACQp0Jm3L0PZYKCEHDeXX1M130_provenance.
- NP791147.RAGtwiNCl_G2SFBL4spgmeSbQMVoIDHiNscgfZkroEYFQ130_assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP791147.RAGtwiNCl_G2SFBL4spgmeSbQMVoIDHiNscgfZkroEYFQ130_provenance.
- NP791148.RAEpD3Fsj86vDPX00uxia4sDZhL5L1nOEN69Y6Gpr9wOY130_assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP791148.RAEpD3Fsj86vDPX00uxia4sDZhL5L1nOEN69Y6Gpr9wOY130_provenance.
- NP370478.RAsIjrzZRWclT7vf9B2yvpX_8kmy_fc74Yx4PbxoDK8Xo130_assertion description "[MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370478.RAsIjrzZRWclT7vf9B2yvpX_8kmy_fc74Yx4PbxoDK8Xo130_provenance.